Roivant Retained Earnings from 2010 to 2025

ROIV Stock

USD 10.67 0.16 1.48%

Roivant Sciences Retained Earnings yearly trend continues to be fairly stable with very little volatility. Retained Earnings are likely to outpace its year average in 2025. Retained Earnings is the cumulative amount of net income that Roivant Sciences retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. View All Fundamentals

Retained Earnings

First Reported

2010-12-31

Previous Quarter

662.6 M

Current Value

695.7 M

Quarterly Volatility

1.3 B

Credit Downgrade

Yuan Drop

Covid

Check Roivant Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Roivant Sciences' main balance sheet or income statement drivers, such as Discontinued Operations of 97.9 M, Depreciation And Amortization of 18.8 M or Interest Expense of 42 M, as well as many indicators such as Price To Sales Ratio of 116, Dividend Yield of 6.0E-4 or PTB Ratio of 2.04. Roivant financial statements analysis is a perfect complement when working with Roivant Sciences Valuation or Volatility modules.

Check out the analysis of Roivant Sciences Correlation against competitors.

For more information on how to buy Roivant Stock please use our How to Invest in Roivant Sciences guide.

Latest Roivant Sciences' Retained Earnings Growth Pattern

Below is the plot of the Retained Earnings of Roivant Sciences over the last few years. It is the cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. Roivant Sciences' Retained Earnings historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Roivant Sciences' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 576.17 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Retained Earnings

Timeline

Roivant Retained Earnings Regression Statistics

	Arithmetic Mean	(1,776,081,469)
	Coefficient Of Variation	(73.53)
	Mean Deviation	991,199,421
	Median	(2,309,737,000)
	Standard Deviation	1,305,891,579
	Sample Variance	1705352.8T
	Range	4.5B
	R-Value	0.56
	Mean Square Error	1251641.9T
	R-Squared	0.31
	Significance	0.02
	Slope	153,941,414
	Total Sum of Squares	25580292.2T

Roivant Retained Earnings History

	2025	695.7 M
	2024	662.6 M
	2023	576.2 M
	2022	-3.8 B
	2021	-2.8 B
	2020	-1.9 B
	2019	-1.1 B

Other Fundumenentals of Roivant Sciences

Retained Earnings Total Equity

Roivant Sciences Retained Earnings component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Property Plant Equipment	Long Term Debt	Short Term Investments	Deferred Long Term Liab	Net Invested Capital	Long Term Investments	Net Working Capital	Long Term Debt Total	Capital Surpluse	Short Long Term Debt	Intangible Assets
Total Assets		1.0	0.41	0.37	-0.98	0.9	0.94	0.98	0.77	1.0	0.08	0.51	0.84	-0.8	0.71	0.98	-0.87	0.98	0.81	0.88	-0.94	-0.9
Total Stockholder Equity	1.0		0.42	0.33	-0.98	0.92	0.92	0.97	0.74	1.0	0.03	0.51	0.82	-0.76	0.68	0.98	-0.88	0.98	0.79	0.87	-0.95	-0.9
Net Tangible Assets	0.41	0.42		0.58	-0.42	0.34	0.45	0.26	0.14	0.39	-0.39	0.89	0.17	-0.36	0.31	0.24	-0.08	0.25	0.14	0.2	-0.18	-0.31
Current Deferred Revenue	0.37	0.33	0.58		-0.34	-0.02	0.65	0.35	0.58	0.33	0.41	0.52	0.51	-0.77	0.75	0.19	0.08	0.19	0.51	0.42	-0.18	-0.25
Net Debt	-0.98	-0.98	-0.42	-0.34		-0.91	-0.91	-0.94	-0.76	-0.98	-0.01	-0.53	-0.84	0.78	-0.72	-0.95	0.83	-0.95	-0.8	-0.83	0.96	0.8
Retained Earnings	0.9	0.92	0.34	-0.02	-0.91		0.7	0.85	0.5	0.91	-0.24	0.45	0.62	-0.48	0.4	0.93	-0.92	0.93	0.58	0.69	-0.9	-0.81
Accounts Payable	0.94	0.92	0.45	0.65	-0.91	0.7		0.92	0.87	0.93	0.26	0.51	0.9	-0.94	0.88	0.86	-0.68	0.87	0.87	0.88	-0.85	-0.81
Net Receivables	0.98	0.97	0.26	0.35	-0.94	0.85	0.92		0.82	0.98	0.27	0.42	0.89	-0.8	0.7	0.97	-0.89	0.97	0.88	0.93	-0.94	-0.9
Total Liab	0.77	0.74	0.14	0.58	-0.76	0.5	0.87	0.82		0.75	0.55	0.35	0.97	-0.87	0.89	0.71	-0.61	0.71	0.97	0.91	-0.79	-0.58
Total Current Assets	1.0	1.0	0.39	0.33	-0.98	0.91	0.93	0.98	0.75		0.07	0.49	0.83	-0.78	0.69	0.98	-0.88	0.98	0.8	0.88	-0.95	-0.91
Short Term Debt	0.08	0.03	-0.39	0.41	-0.01	-0.24	0.26	0.27	0.55	0.07		-0.17	0.48	-0.41	0.39	0.07	-0.07	0.06	0.56	0.41	-0.1	-0.1
Property Plant Equipment	0.51	0.51	0.89	0.52	-0.53	0.45	0.51	0.42	0.35	0.49	-0.17		0.36	-0.36	0.32	0.35	-0.3	0.35	0.37	0.37	-0.33	-0.35
Long Term Debt	0.84	0.82	0.17	0.51	-0.84	0.62	0.9	0.89	0.97	0.83	0.48	0.36		-0.88	0.89	0.8	-0.7	0.8	0.99	0.94	-0.88	-0.65
Short Term Investments	-0.8	-0.76	-0.36	-0.77	0.78	-0.48	-0.94	-0.8	-0.87	-0.78	-0.41	-0.36	-0.88		-0.96	-0.7	0.46	-0.71	-0.85	-0.8	0.72	0.64
Deferred Long Term Liab	0.71	0.68	0.31	0.75	-0.72	0.4	0.88	0.7	0.89	0.69	0.39	0.32	0.89	-0.96		0.61	-0.37	0.61	0.85	0.78	-0.69	-0.49
Net Invested Capital	0.98	0.98	0.24	0.19	-0.95	0.93	0.86	0.97	0.71	0.98	0.07	0.35	0.8	-0.7	0.61		-0.93	1.0	0.77	0.86	-0.96	-0.92
Long Term Investments	-0.87	-0.88	-0.08	0.08	0.83	-0.92	-0.68	-0.89	-0.61	-0.88	-0.07	-0.3	-0.7	0.46	-0.37	-0.93		-0.93	-0.7	-0.81	0.9	0.85
Net Working Capital	0.98	0.98	0.25	0.19	-0.95	0.93	0.87	0.97	0.71	0.98	0.06	0.35	0.8	-0.71	0.61	1.0	-0.93		0.76	0.86	-0.96	-0.92
Long Term Debt Total	0.81	0.79	0.14	0.51	-0.8	0.58	0.87	0.88	0.97	0.8	0.56	0.37	0.99	-0.85	0.85	0.77	-0.7	0.76		0.94	-0.84	-0.65
Capital Surpluse	0.88	0.87	0.2	0.42	-0.83	0.69	0.88	0.93	0.91	0.88	0.41	0.37	0.94	-0.8	0.78	0.86	-0.81	0.86	0.94		-0.87	-0.81
Short Long Term Debt	-0.94	-0.95	-0.18	-0.18	0.96	-0.9	-0.85	-0.94	-0.79	-0.95	-0.1	-0.33	-0.88	0.72	-0.69	-0.96	0.9	-0.96	-0.84	-0.87		0.78
Intangible Assets	-0.9	-0.9	-0.31	-0.25	0.8	-0.81	-0.81	-0.9	-0.58	-0.91	-0.1	-0.35	-0.65	0.64	-0.49	-0.92	0.85	-0.92	-0.65	-0.81	0.78

Click cells to compare fundamentals

About Roivant Sciences Financial Statements

Roivant Sciences investors use historical fundamental indicators, such as Roivant Sciences' Retained Earnings, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Roivant Sciences. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Retained Earnings	662.6 M	695.7 M
Retained Earnings Total Equity	-3.4 B	-3.6 B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Roivant Stock Analysis

When running Roivant Sciences' price analysis, check to measure Roivant Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roivant Sciences is operating at the current time. Most of Roivant Sciences' value examination focuses on studying past and present price action to predict the probability of Roivant Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roivant Sciences' price. Additionally, you may evaluate how the addition of Roivant Sciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC